These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 12675917

  • 1. The sensitivity of catecholamine release to botulinum toxin C1 and E suggests selective targeting of vesicles set into the readily releasable pool.
    Stigliani S, Raiteri L, Fassio A, Bonanno G.
    J Neurochem; 2003 Apr; 85(2):409-21. PubMed ID: 12675917
    [Abstract] [Full Text] [Related]

  • 2. Evidence for calcium-dependent vesicular transmitter release insensitive to tetanus toxin and botulinum toxin type F.
    Fassio A, Sala R, Bonanno G, Marchi M, Raiteri M.
    Neuroscience; 1999 Mar; 90(3):893-902. PubMed ID: 10218789
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ca2+-induced changes in SNAREs and synaptotagmin I correlate with triggered exocytosis from chromaffin cells: insights gleaned into the signal transduction using trypsin and botulinum toxins.
    Lawrence GW, Dolly JO.
    J Cell Sci; 2002 Jul 01; 115(Pt 13):2791-800. PubMed ID: 12077369
    [Abstract] [Full Text] [Related]

  • 10. Botulinum neurotoxin E-insensitive mutants of SNAP-25 fail to bind VAMP but support exocytosis.
    Washbourne P, Bortoletto N, Graham ME, Wilson MC, Burgoyne RD, Montecucco C.
    J Neurochem; 1999 Dec 01; 73(6):2424-33. PubMed ID: 10582602
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential.
    Meng J, Wang J, Lawrence G, Dolly JO.
    J Cell Sci; 2007 Aug 15; 120(Pt 16):2864-74. PubMed ID: 17666428
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ca2+ or Sr2+ partially rescues synaptic transmission in hippocampal cultures treated with botulinum toxin A and C, but not tetanus toxin.
    Capogna M, McKinney RA, O'Connor V, Gähwiler BH, Thompson SM.
    J Neurosci; 1997 Oct 01; 17(19):7190-202. PubMed ID: 9295365
    [Abstract] [Full Text] [Related]

  • 16. Molecular scaffold reorganization at the transmitter release site with vesicle exocytosis or botulinum toxin C1.
    Stanley EF, Reese TS, Wang GZ.
    Eur J Neurosci; 2003 Oct 01; 18(8):2403-7. PubMed ID: 14622203
    [Abstract] [Full Text] [Related]

  • 17. Distinct kinetic changes in neurotransmitter release after SNARE protein cleavage.
    Sakaba T, Stein A, Jahn R, Neher E.
    Science; 2005 Jul 15; 309(5733):491-4. PubMed ID: 16020741
    [Abstract] [Full Text] [Related]

  • 18. Selective cleavage of SNAREs in sensory neurons unveils protein complexes mediating peptide exocytosis triggered by different stimuli.
    Meng J, Dolly JO, Wang J.
    Mol Neurobiol; 2014 Oct 15; 50(2):574-88. PubMed ID: 24604356
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.